SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $311,000 | -53.7% | 1,955 | -72.1% | 0.02% | -62.7% |
Q4 2018 | $671,000 | +18.8% | 7,000 | +75.0% | 0.05% | +64.5% |
Q3 2018 | $565,000 | -9.7% | 4,000 | 0.0% | 0.03% | -13.9% |
Q2 2018 | $626,000 | -35.2% | 4,000 | -33.3% | 0.04% | -28.0% |
Q1 2018 | $966,000 | -58.1% | 6,000 | -57.1% | 0.05% | -52.8% |
Q4 2017 | $2,306,000 | +85.1% | 14,000 | -30.0% | 0.11% | +92.7% |
Q3 2017 | $1,246,000 | -35.6% | 20,000 | -17.7% | 0.06% | -32.9% |
Q2 2017 | $1,936,000 | -45.1% | 24,300 | -51.1% | 0.08% | -54.2% |
Q1 2017 | $3,528,000 | -60.4% | 49,650 | -67.5% | 0.18% | -37.2% |
Q4 2015 | $8,919,000 | – | 152,985 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
Diametric Capital, LP | 19,393 | $626,000 | 0.46% |